![iStock11952808291080x675](/-/media/images/publications/2021/05/ptab-declines-to-enter-adverse-judgment-against-preinstitution-disclaimed-claims/articleimage/istock11952808291080x675.jpeg?rev=6719892e2f494cbc9fcb9093ec943fe3&la=en&h=675&w=1080&hash=AAD1D9BBEBE4179DC14FFB06A4BF3E3B)
PTAB Declines To Enter Adverse Judgment Against Pre-Institution Disclaimed Claims, PTAB Litigation Blog
Visit the PTAB Litigation Blog.
Although the Federal Circuit had previously held that the PTAB may enter adverse judgment when a patent owner disclaims all claims challenged in an inter partes review (“IPR”) petition before an institution decision, in Pfizer, Inc. v. UniQure Biopharma B.V., IPR2020-00388, Paper 52 (Mar. 25, 2021), the PTAB declined to enter adverse judgment against challenged claims that the patent owner had disclaimed before the PTAB instituted review.